Hypertension: Potential Player in Cardiovascular Disease Incidence in Preeclampsia

Preeclampsia (PE) is one of the complications, that threatens pregnant mothers during pregnancy. According to studies, it accounts for 3-7% of all pregnancies, and also is effective in preterm delivery. PE is the third leading cause of death in pregnant women. High blood pressure in PE can increase the risk of developing cardiovascular disease (CVD) in cited individuals, and is one of the leading causes of death in PE individuals. Atrial natriuretic peptide (ANP), Renin-Angiotensin system and nitric oxide (NO) are some of involved factors in regulating blood pressure. Therefore, by identifying the signaling pathways, that are used by these molecules to regulate and modulate blood pressure, appropriate treatment strategies can be provided to reduce blood pressure through target therapy in PE individuals; consequently, it can reduce CVD risk and mortality.

Automated summary

Preeclampsia (PE) is a complication during pregnancy that poses a threat to pregnant women, with high blood pressure being one of its main symptoms. Studies have shown that PE can increase the risk of developing cardiovascular disease and mortality. By understanding the signaling pathways involved in blood pressure regulation, appropriate treatment strategies can be developed to reduce blood pressure in PE individuals, thus reducing the risk of cardiovascular disease and mortality.